Virology

Millions of people worldwide are living with #HepatitisC. On #WorldHepatitisDay, learn about our commitment to treating #HCV and the role of partnerships to achieve the World Health Organization’s HCV elimination goal by 2030. ⬇ [Video description: Interview with Brian Conway, medical director, Vancouver Infectious Diseases Centre. On-screen text reads, “Globally, an estimated 50 million people have HCV, with about 1 million new infections occurring per year. Join us as we work to help eliminate Hepatitis C.”]

Leading up to #WorldHepatitisDay, we’re raising awareness of the impact of #MentalHealth and addiction in #HCV care. Learn more about the importance of addressing mental health in HCV. ⬇ [Video description: Interview with Filipe Calinas, gastroenterologist and pathologist, Certeario Hospital. On-screen text reads, “Cognitive decline and psychological disorders affect up to 50% of people with HCV. We are committed to improving the lives of people living with Hepatitis C.”]

It’s critical that we all work together to reach the World Health Organization’s goal of #HepatitisC elimination by 2030. Ahead of #WorldHepatitisDay, we’re emphasizing our focus on #HCV elimination and advancing progress in the global community. Hear more below. [Video description: An interview with Dimitri Semizarov, global medical affairs therapeutic area lead at AbbVie. On-screen text reads, “Together, global leaders can help eliminate hepatitis C by 2030. Join us in helping move the world closer to eliminating Hepatitis C.”]

More than 800,000 people worldwide are diagnosed with #LiverCancer each year. This #WorldLiverDay, we’re raising awareness of the link between Hepatitis C and liver cancer and importance of early diagnosis and access to care, including in underserved communities. Explore how we’re supporting the World Health Organization's goal of #HCV elimination by 2030: https://bit.ly/3w1teru [Video description: On-screen text reads, “Did you know… Approximately 90% of primary liver cancers are hepatocellular carcinomas (HCCs) and virtually all HCCs arise in patients with chronic liver diseases such as HCV (hepatitis C virus).”]

Millions of people worldwide are living with #HCV. We’re at the #WorldHepatitisSummit discussing the importance of multi-stakeholder collaboration to achieve HCV elimination and advance progress in the global community. Learn more about our work in this area: https://lnkd.in/g4vGAPBi [Image description: On-screen text reads, “Today, an estimated 58 million people worldwide have chronic HCV. Up to 70% of people living with HCV may also have depressive orders.”]

Testing is the only way to diagnose hepatitis C virus (#HCV). We support initiatives around the globe providing access to testing and closing care gaps, including programs such as the Prison X Project in Taiwan. Learn more about this HCV elimination effort on page 33 of our ESG Action Report: https://bit.ly/3T2JTnA

Stigma impacting communities at-risk of hepatitis C virus (HCV) can result in health consequences. That’s why we work alongside the global patient advocacy community to help reduce barriers to care and support access to testing and treatment. Hear from an #HCV expert on the importance of reaching these communities. [Video description: Michael Ninburg, former president of the World Hepatitis Alliance, on the barrier’s communities face seeking care for HCV.]

There are 7 years left to reach the World Health Organization’s goal of eliminating hepatitis C virus (#HCV). To help advance these efforts, we’re engaging in hundreds of micro-elimination projects targeting at-risk communities – from education initiatives to closing gaps in care paths. See page 33 of our 2022 ESG Action report for more: https://bit.ly/3QGvNqj [Video description: On-screen text reads, “In 2017, 71 million people worldwide had chronic HCV. Today, an estimated 58 million people worldwide have chronic HCV. Work remains, but progress continues to pave the way toward elimination.”]

By providing communities around the world with access to care, testing and educational resources, we’re continuing to support the World Health Organization’s 2030 hepatitis C virus (#HCV) elimination goal. See page 33 of our 2022 ESG Action Report for more about our work reducing HCV’s global incidence: https://bit.ly/3tD6E6Y [Video description: On-screen text reads, “Out of the 58 million people worldwide living with chronic hepatitis C virus in 2019… Only 20% of them were diagnosed… and 13% were treated for the infection.”]

During #LiverCancerAwarenessMonth, we’re sharing education around one of the major risk factors for #LiverCancer: hepatitis C virus (#HCV). Explore this factsheet from the World Health Organization to learn about the global burden of hepatitis, and why partnerships like ours are key to its elimination: https://bit.ly/3RX8cTa [Video description: On-screen text reads, “Did you know… Approximately 90% of primary liver cancers are hepatocellular carcinomas (HCCs) and virtually all HCCs arise in patients with chronic liver diseases such as HCV (hepatitis C virus).”]